Catalyst
Slingshot members are tracking this event:
PDUFA Date of February 17, 2017 for Janssen's (JNJ) Daratumumab in Relapsed Multiple Myeloma
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| JNJ |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 21, 2016
Occurred Source:
https://www.janssen.com/us/sites/www_janssen_com_usa/files/daratumumab_combo_approval_press_release_final.pdf
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Pdufa Date, Daratumumab, Fda, Relapsed Multiple Myeloma
